Drug Reference
Lopinavir / Ritonavir
Antivirals for treatment of HIV infections, combinations
Fact box
- Therapeutic class
- Antivirals for treatment of HIV infections, combinations
Brand names
Kaletra
Available as
133 MG · Oral Capsule80 MG/ML · Oral Solution200 MG · Oral Tablet100 MG · Oral Tablet
Multi-ingredient product
LopinavirRitonavir
This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.
Current FDA labels (DailyMed)
- KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]
- LOPINAVIR AND RITONAVIR TABLET, FILM COATED [MACLEODS PHARMACEUTICALS LIMITED]
- KALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [NUCARE PHARMACEUTICALS,INC.]
- LOPINAVIR AND RITONAVIR TABLET, FILM COATED [LAURUS LABS LIMITED]
- LOPINAVIR AND RITONAVIR TABLET, FILM COATED [NUCARE PHARMACEUTICALS,INC.]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.